Skip to main content
. 2017 Oct 23;2(10):7085–7095. doi: 10.1021/acsomega.7b01234

Scheme 1. Schematic Illustration of the Combination of Microreactors and HepG2 Cells.

Scheme 1

(a) Assembly: schematic illustration of the Alg particle fabrication using D-μF and their coating with poly(l-lysine) (PLL) or cholesterol-modified poly(methacrylic acid) (PMA) (PMAc) (right inset). Two types of microreactors are assembled: AlgLcat consisting of Alg carrier particles with entrapped catalase-loaded liposomal subunits (Lcat) and Algcat consisting of Alg carrier particles with entrapped catalase (cat) (left inset). (b) Microreactors and HepG2 cells are mixed in solution, followed by their co-culturing. The HepG2 cells are allowed to be in planar cell culture and in cell aggregates. (c) These combinations of synthetic microreactors and HepG2 cells are exposed to hydrogen peroxide (H2O2), and the ability of the artificial partner to support the viability of the HepG2 cells is assessed.